Regional differences in biologic and surgical treatment of inflammatory bowel disease in Norway 2011-2019

被引：0
|
作者：
Anisdahl, K. [1 ,2 ]
Lirhus, S. S. [3 ]
Medhus, A. W. [1 ]
Moum, B. [2 ,4 ]
Melberg, H. O. [3 ,5 ]
Hoivik, M. L. [1 ,2 ]
机构：
[1] Oslo Univ Hosp, Dept Gastroenterol, Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway
[4] Ostfold Hosp Trust, Dept Gastroenterol, Oslo, Norway
[5] Univ Tromso, Dept Community Med, Tromso, Norway
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P882
引用
收藏
页码：999 / 1001
页数：3
相关论文
共 50 条
  • [21] Biologic therapy of inflammatory bowel disease
    Baumgart, DC
    Wiedenmann, B
    Dignass, AU
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2003, 41 (10): : 1017 - 1032
  • [22] The social gradient in institutional trust from 2011-2019 in the general population in Norway
    Ihlebaek, C.
    Stenmarch, C.
    Nordboe, E. C. A.
    Skipstein, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [23] The Influence of the Introduction of Biologic Agents on Surgical Intervention in Paediatric Inflammatory Bowel Disease
    Bethell, George S.
    Ashton, James J.
    Adams, Stephen
    Beattie, R. Mark
    Hall, Nigel J.
    Stanton, Michael P.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 75 (03): : 308 - 312
  • [24] Surgical Outcomes in Inflammatory Bowel Disease Patients and the Potential Impact of Biologic Therapies
    Cima, Robert R.
    SEMINARS IN COLON AND RECTAL SURGERY, 2012, 23 (02) : 89 - 93
  • [25] Satisfaction with treatment amongst inflammatory bowel disease patients receiving subcutaneous biologic treatment and infused biologic treatment
    Wang, S.
    Piercy, J.
    Jakubanis, R.
    Skup, M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S400 - S400
  • [26] Emerging role of dual biologic therapy for the treatment of inflammatory bowel disease
    Matthew D McCormack
    Natasha A Wahedna
    David Aldulaimi
    Peter Hawker
    World Journal of Clinical Cases, 2023, (12) : 2621 - 2630
  • [27] Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease
    Florholmen, Jon
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (01) : 43 - 52
  • [28] Risk of Nephrolithiasis in Patients with Inflammatory Bowel Disease Receiving Biologic Treatment
    Alameddine, Zakaria
    Melhem, Racha Abi
    Dimachkie, Reem
    Rabah, Hussein
    Chehab, Hamed
    El Khoury, Michel
    Qaqish, Faris
    Stefanov, Dimitre
    El-Sayegh, Suzanne
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [29] Oral Tacrolimus for the Treatment of Refractory Inflammatory Bowel Disease in the Biologic Era
    Thin, Lena W. Y.
    Murray, Kevin
    Lawrance, Ian C.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (07) : 1490 - 1498
  • [30] Economic Burden of Biologic Treatment in Patients With Inflammatory Bowel Disease in the US
    Bornheimer, Rebecca
    Hass, Steve
    Nag, Arpita
    Oster, Gerry
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S433 - S434
12345